| Date | Time | Source | Headline | Symbol | Company |
| 11/16/2016 | 5:04PM | Business Wire | ARIAD Announces Data Presentations at the World Conference on Lung Cancer | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/14/2016 | 7:35AM | Business Wire | ARIAD Announces Launch of Inaugural ALK+ Day During Lung Cancer Awareness Month | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/09/2016 | 7:35AM | Business Wire | ARIAD Announces Phase 1/2 Trial Data on Investigational Drug Brigatinib Published in The Lancet Oncology | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/08/2016 | 5:34PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/07/2016 | 7:41AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/07/2016 | 7:35AM | Business Wire | ARIAD Reports Third Quarter 2016 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/02/2016 | 7:35AM | Business Wire | ARIAD to Present at the Jefferies 2016 London Healthcare Conference | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 11/01/2016 | 7:35AM | Business Wire | ARIAD to Webcast Conference Call on Third Quarter 2016 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/31/2016 | 7:35AM | Business Wire | ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/28/2016 | 1:42PM | Business Wire | SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Ariad Pharmaceuticals Inc. & Advises Investors with Losses t... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/28/2016 | 12:33PM | Business Wire | Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ariad Pharmaceuticals Inc. Investors | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/26/2016 | 7:35AM | Business Wire | ARIAD Announces Publication of the Preclinical Profile of Brigatinib in the Journal Clinical Cancer Research | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/25/2016 | 4:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/21/2016 | 9:39AM | Dow Jones News | U.S. Hot Stocks: Hot Stocks to Watch | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/20/2016 | 4:21PM | Business Wire | ARIAD Reaffirms Commitment to Discovering and Developing Treatments for Patients with Rare Cancers | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/10/2016 | 7:35AM | Business Wire | ARIAD Presents Updated Long-Term Follow-up Results from the Phase 1/2 Trial on Investigational Drug Brigatinib at 2016 ESMO M... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/07/2016 | 12:21PM | PR Newswire (US) | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ariad Pharmaceuticals, Inc. (ARIA) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/07/2016 | 11:08AM | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ariad Pharmaceuticals, Inc. - ARIA | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 10/05/2016 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/30/2016 | 9:00AM | PR Newswire (US) | Biotechs and the Advancements in Cancer Oriented Clinical Trials | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/29/2016 | 4:37PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2016 | 4:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2016 | 4:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2016 | 7:35AM | Business Wire | ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/23/2016 | 5:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/16/2016 | 5:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/15/2016 | 7:35AM | Business Wire | ARIAD Announces Ponatinib Data Presentations at European School of Haematology Annual John Goldman Conference on Chronic Myel... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/12/2016 | 9:51AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/30/2016 | 4:49PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/30/2016 | 7:35AM | Business Wire | ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |